RC

Robert L. Coffman

DT Dynavax Technologies: 23 patents #1 of 52Top 2%
SC Schering: 3 patents #883 of 2,442Top 40%
Merck: 2 patents #3,919 of 9,382Top 45%
AA Aluminum Company Of America: 1 patents #495 of 1,017Top 50%
TS Trisalus Life Sciences: 1 patents #6 of 20Top 30%
Overall (All Time): #127,956 of 4,157,543Top 4%
29
Patents All Time

Issued Patents All Time

Showing 25 most recent of 29 patents

Patent #TitleCo-InventorsDate
12378255 Toll-like receptor antagonist compounds and methods of use Albert Frederick Candia, III, Richard Thomas Beresis 2025-08-05
12296002 Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Tsun-Yung Kuo, Charles CHEN, Chung-Chin Wu, Yi-Jiun Lin, Meei-Yun Lin +5 more 2025-05-13
11981670 Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof Stewart Chipman, Radwan Kiwan, Melissa A. KACHURA 2024-05-14
11918648 Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer Ying Yu, Andrew Evan Denker, Svetlana Sadekova, Uyen Phan, Robert A. Kastelein +3 more 2024-03-05
11827641 Toll-like receptor antagonist compounds and methods of use Albert Frederick Candia, III, Richard Thomas Beresis 2023-11-28
11370794 Toll-like receptor antagonist compounds and methods of use Albert Frederick Candia, III, Richard Thomas Beresis 2022-06-28
11124510 Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof Stewart Chipman, Radwan Kiwan, Melissa A. KACHURA 2021-09-21
10751412 Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer Ying Yu, Andrew Evan Denker, Svetlana Sadekova, Uyen Phan, Robert A. Kastelein +3 more 2020-08-25
10722591 Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof Stewart Chipman, Radwan Kiwan, Samuel Zalipsky, Gary S. Ott 2020-07-28
10548975 Branched chimeric compounds, and methods of use thereof Gary S. Ott, Robert J. Milley, Radwan Kiwan, Holger Kanzler 2020-02-04
10369168 Administration of polynucleotide toll-like receptor 9 agonists for treating cancer Cristiana Guiducci 2019-08-06
10350290 Linear chimeric compounds and methods of use thereof Gary S. Ott, Robert J. Milley, Radwan Kiwan, Holger Kanzler 2019-07-16
10111899 Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung Cristiana Guiducci 2018-10-30
9993495 Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung Cristiana Guiducci 2018-06-12
9950064 Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof Gary S. Ott, Robert J. Milley, Radwan Kiwan, Holger Kanzler 2018-04-24
9476053 Methods and compositions for inhibition of immune responses and autoimmunity Franck Barrat, Tracy Matray, Cristiana Guiducci 2016-10-25
9347064 Methods of treatment using TLR7 and/or TLR9 inhibitors Franck Barrat, Cristiana Guiducci 2016-05-24
9333254 Long term disease modification using immunostimulatory oligonucleotides Edith M. Hessel 2016-05-10
9063123 Transgenic mice expressing human toll-like receptor 8 Franck Barrat, Cristiana Guiducci 2015-06-23
8962579 Methods and compositions for inhibition of immune responses and autoimmunity Franck Barrat, Tracy Matray, Cristiana Guiducci 2015-02-24
8940310 Methods of treatment using TLR7 and/or TLR9 inhibitors Franck Barrat, Cristiana Guiducci 2015-01-27
8815817 Long term disease modification using immunostimulatory oligonucleotides Edith M. Hessel 2014-08-26
8759305 Methods and compositions for inhibition of innate immune responses and autoimmunity Franck Barrat 2014-06-24
8252757 Long term disease modification using immunostimulatory oligonucleotides Edith M. Hessel 2012-08-28
6207155 Method of eosinophil depletion with antibody to CCR 3 receptor J. Christopher Grimaldi, Maureen Howard 2001-03-27